Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Safety and Efficacy of RGH-188 in the Acute Exacerbation of Schizophrenia

NCT00694707 is registered in ClinicalTrials.gov with Forest Laboratories as lead sponsor.

NCT NCT00694707
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00694707 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Safety and Efficacy of RGH-188 in the Acute Exacerbation of Schizophrenia
Lead sponsor
Forest Laboratories
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2008
Completion date
August 31, 2009
Enrollment
732 (actual)
Sites
65

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia